1 December 2024 false No description of principal activity Taxfiler 2024.6 15252794 business:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 15252794 2024-11-30 15252794 2024-12-01 2025-11-30 15252794 business:AuditExempt-NoAccountantsReport 2024-12-01 2025-11-30 15252794 business:FilletedAccounts 2024-12-01 2025-11-30 15252794 2025-11-30 15252794 business:Director1 2024-12-01 2025-11-30 15252794 2024-11-30 15252794 core:ShareCapital core:PreviouslyStatedAmount 2025-11-30 15252794 core:ShareCapital core:PreviouslyStatedAmount 2024-11-30 15252794 core:PreviouslyStatedAmount 2025-11-30 15252794 core:PreviouslyStatedAmount 2024-11-30 15252794 business:SmallEntities 2024-12-01 2025-11-30 15252794 countries:EnglandWales 2024-12-01 2025-11-30 15252794 2024-11-01 2024-11-30 iso4217:GBP xbrli:pure
Company Registration No. 15252794 (England and Wales)
Pharmarevive Limited Unaudited accounts for the year ended 30 November 2025
Pharmarevive Limited Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Pharmarevive Limited Company Information for the year ended 30 November 2025
Director
Mr Ali El Kadi
Company Number
15252794 (England and Wales)
- 3 -
Pharmarevive Limited Statement of financial position as at 30 November 2025
2025
2024
Notes
£
£
Current assets
Cash at bank and in hand
100
100
Net current assets
100
100
Net assets
100
100
Capital and reserves
Called up share capital
100
100
Shareholders' funds
100
100
For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 17 April 2026 and were signed on its behalf by
Mr Ali El Kadi Director Company Registration No. 15252794
- 4 -
Pharmarevive Limited Notes to the Accounts for the year ended 30 November 2025
1
Statutory information
Pharmarevive Limited is a private company, limited by shares, registered in England and Wales, registration number 15252794.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Average number of employees
During the year the average number of employees was 0 (2024: 0).
- 5 -